These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

425 related articles for article (PubMed ID: 33096898)

  • 1. Use of Biodegradable, Chitosan-Based Nanoparticles in the Treatment of Alzheimer's Disease.
    Manek E; Darvas F; Petroianu GA
    Molecules; 2020 Oct; 25(20):. PubMed ID: 33096898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chitosan as a suitable nanocarrier material for anti-Alzheimer drug delivery.
    Sarvaiya J; Agrawal YK
    Int J Biol Macromol; 2015 Jan; 72():454-65. PubMed ID: 25199867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chrysin-Loaded Chitosan Nanoparticle-Mediated Neuroprotection in Aβ
    Saleem S; Banerjee R; Rajesh Kannan R
    ACS Chem Neurosci; 2022 Jul; 13(13):2017-2034. PubMed ID: 35696319
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complexation as an approach to entrap cationic drugs into cationic nanoparticles administered intranasally for Alzheimer's disease management: preparation and detection in rat brain.
    Hanafy AS; Farid RM; ElGamal SS
    Drug Dev Ind Pharm; 2015; 41(12):2055-68. PubMed ID: 26133084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurotherapeutic applications of nanoparticles in Alzheimer's disease.
    Sahni JK; Doggui S; Ali J; Baboota S; Dao L; Ramassamy C
    J Control Release; 2011 Jun; 152(2):208-31. PubMed ID: 21134407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multifunctional Nanocarriers for Alzheimer's Disease: Befriending the Barriers.
    Ansari MA; Tripathi T; Venkidasamy B; Monziani A; Rajakumar G; Alomary MN; Alyahya SA; Onimus O; D'souza N; Barkat MA; Al-Suhaimi EA; Samynathan R; Thiruvengadam M
    Mol Neurobiol; 2024 May; 61(5):3042-3089. PubMed ID: 37966683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nose-to-brain drug delivery: An update on clinical challenges and progress towards approval of anti-Alzheimer drugs.
    Agrawal M; Saraf S; Saraf S; Antimisiaris SG; Chougule MB; Shoyele SA; Alexander A
    J Control Release; 2018 Jul; 281():139-177. PubMed ID: 29772289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeted nanoparticles for drug delivery through the blood-brain barrier for Alzheimer's disease.
    Roney C; Kulkarni P; Arora V; Antich P; Bonte F; Wu A; Mallikarjuana NN; Manohar S; Liang HF; Kulkarni AR; Sung HW; Sairam M; Aminabhavi TM
    J Control Release; 2005 Nov; 108(2-3):193-214. PubMed ID: 16246446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alzheimer's Disease Targeted Nano-Based Drug Delivery Systems.
    Altinoglu G; Adali T
    Curr Drug Targets; 2020; 21(7):628-646. PubMed ID: 31744447
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alzheimer's Disease and Parkinson's Disease: A Review of Current Treatment Adopting a Nanotechnology Approach.
    Trompetero A; Gordillo A; Del Pilar MC; Cristina VM; Bustos Cruz RH
    Curr Pharm Des; 2018; 24(1):22-45. PubMed ID: 28847307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microfluidic Synthesis of Ultrasmall Chitosan/Graphene Quantum Dots Particles for Intranasal Delivery in Alzheimer's Disease Treatment.
    Mohebichamkhorami F; Faizi M; Mahmoudifard M; Hajikarim-Hamedani A; Mohseni SS; Heidari A; Ghane Y; Khoramjouy M; Khayati M; Ghasemi R; Zali H; Hosseinzadeh S; Mostafavi E
    Small; 2023 Oct; 19(40):e2207626. PubMed ID: 37309299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alzheimer's disease and its treatment by different approaches: A review.
    Srivastava S; Ahmad R; Khare SK
    Eur J Med Chem; 2021 Apr; 216():113320. PubMed ID: 33652356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intranasal Piperine-Loaded Chitosan Nanoparticles as Brain-Targeted Therapy in Alzheimer's Disease: Optimization, Biological Efficacy, and Potential Toxicity.
    Elnaggar YS; Etman SM; Abdelmonsif DA; Abdallah OY
    J Pharm Sci; 2015 Oct; 104(10):3544-56. PubMed ID: 26147711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Memantine loaded PLGA PEGylated nanoparticles for Alzheimer's disease: in vitro and in vivo characterization.
    Sánchez-López E; Ettcheto M; Egea MA; Espina M; Cano A; Calpena AC; Camins A; Carmona N; Silva AM; Souto EB; García ML
    J Nanobiotechnology; 2018 Mar; 16(1):32. PubMed ID: 29587747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic potentials of plant iridoids in Alzheimer's and Parkinson's diseases: A review.
    Dinda B; Dinda M; Kulsi G; Chakraborty A; Dinda S
    Eur J Med Chem; 2019 May; 169():185-199. PubMed ID: 30877973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent Trends in Nano-Particulate Carriers for the Diagnosis and Treatment of Alzheimer's Disease.
    Mazahir F; Yadav AK
    CNS Neurol Disord Drug Targets; 2023; 22(4):477-499. PubMed ID: 35450536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chitosan hydrogel nanoparticle enhance therapeutic effect of bovine umbilical mesenchymal stem cell conditioned medium on canine cognitive dysfunction or canine Alzheimer's like mediated by inhibition of neuronal apoptotic.
    Wihadmadyatami H; Zulfikar MA; Herawati H; Pratama DAOA; Saragih GR; Kustiati U; Handayani AN
    Open Vet J; 2023 Dec; 13(12):1504-1516. PubMed ID: 38292722
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biomaterials in treatment of Alzheimer's disease.
    Agrawal M; Prathyusha E; Ahmed H; Dubey SK; Kesharwani P; Singhvi G; Naidu VGM; Alexander A
    Neurochem Int; 2021 May; 145():105008. PubMed ID: 33684545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brain targeted peptide-functionalized chitosan nanoparticles for resveratrol delivery: Impact on insulin resistance and gut microbiota in obesity-related Alzheimer's disease.
    Yang L; Wang Y; Li Z; Wu X; Mei J; Zheng G
    Carbohydr Polym; 2023 Jun; 310():120714. PubMed ID: 36925241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Applications of Nanoparticles in Alzheimer's Disease.
    Liu Y; Shen Y
    J Alzheimers Dis; 2023; 96(2):459-471. PubMed ID: 37807779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.